News
XTNT
0.4800
-7.60%
-0.0395
Xtant Medical Holdings, Inc. Common Stock Q1 EPS $(0.03) Vs. $0.00 YoY, Sales $13.00M Miss $14.02M Estimate
Xtant Medical Holdings, Inc. Common Stock (AMEX:XTNT) reported quarterly losses of $(0.03) per share. The company reported quarterly sales of $13.00 million which missed the analyst consensus estimate of $14.02 million
Benzinga · 05/05 12:21
Xtant Medical GAAP EPS of -$0.03, revenue of $13M
Xtant Medical press release (NYSE:XTNT): Q1 GAAP EPS of -$0.03. Revenue of $13M (+3.7% Y/Y).
Seekingalpha · 05/05 12:02
-- Earnings Flash (XTNT) XTANT MEDICAL Reports Q1 Revenue $13M
MT Newswires · 05/05 08:13
BRIEF-Xtant Medical Appoints Scott Neils As Chief Financial Officer
reuters.com · 05/02 13:34
Xtant Medical Names Scott Neils as CFO
MT Newswires · 05/02 11:47
Xtant Medical to Issue First Quarter 2022 Financial Results on May 5, 2022
BELGRADE, Mont., April 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financ...
GlobeNewswire · 04/28 12:30
Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 22, 2022
BELGRADE, Mont., March 15, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and...
GlobeNewswire · 03/15 12:00
Xtant Medical Holdings, Inc. Common Stock Q4 EPS $(0.03) Down From $(0.01) YoY, Sales $13.97M Miss $14.02M Estimate
Xtant Medical Holdings, Inc. Common Stock (AMEX:XTNT) reported quarterly losses of $(0.03) per share. This is a 200 percent decrease over losses of $(0.01) per share from the same period last year. The company reported
Benzinga · 03/08 12:19
Xtant Medical GAAP EPS of -$0.03, revenue of $13.97M
Xtant Medical press release (NYSE:XTNT): Q4 GAAP EPS of -$0.03. Revenue of $13.97M (-0.4% Y/Y). CEO comment: "As part of our strategic plan, we launched four new products, and we
Seekingalpha · 03/08 12:03
-- Earnings Flash (XTNT) XTANT MEDICAL Reports Q4 Revenue $14M
MT Newswires · 03/08 07:15
A Look Into Healthcare Sector Value Stocks
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most ...
Benzinga · 03/07 14:43
Xtant Medical to Issue Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022
BELGRADE, Mont., March 01, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financ...
GlobeNewswire · 03/01 13:30
Xtant Medical to Present at the H.C. Wainwright BioConnect Virtual Conference
BELGRADE, Mont., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executiv...
GlobeNewswire · 01/04 13:00
Xtant Medical appoints interim CFO from within ranks
Xtant Medical (NYSE:XTNT) appointed Scott Neils as interim CFO, succeeding Greg Jensen, the company’s current vice president, finance and CFO, effective Jan. 3. Neils has served as the company’s controller since
Seekingalpha · 01/03 13:12
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
Here's a roundup of top developments in the biotech space over the last 24 hours.
Benzinga · 11/12/2021 12:40
Xtant Medical reports Q3 results
Xtant Medical (NYSE:XTNT): Q3 GAAP EPS of -$0.02. Revenue of $13.8M (-1.4% Y/Y) Shares -1.80% PM. Press Release
Seekingalpha · 11/12/2021 12:08
Xtant Medical Honors Donor Hero on the Donate Life Rose Parade® Float
Company Among Sponsors of Donate Life Float at 2022 Rose Parade Samuel Lee Becker Samuel Lee Becker BELGRADE, Mont., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgic...
GlobeNewswire · 10/19/2021 12:00
Xtant Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
BELGRADE, Mont., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executi...
GlobeNewswire · 09/07/2021 12:00
-- Earnings Flash (XTNT) XTANT MEDICAL Posts Q2 Revenue $15M
MT Newswires · 08/05/2021 07:17
More
Webull provides a variety of real-time XTNT stock news. You can receive the latest news about Xtant Medical through multiple platforms. This information may help you make smarter investment decisions.
About XTNT
Xtant Medical Holdings, Inc. is a medical technology company, which is focused on the designing, development and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. The Company’s products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar and interbody spine. It promotes and sells its products in the United States through independent distributors and stocking agents. The Company also maintains a national accounts program to enable its agents to gain access to independent health delivery network hospitals and through group purchasing organizations (GPOs). Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts.